Specific protein degradation is currently being explored in its place technique in cancer, whereby the pure protein degradation procedure is co-opted for therapeutic functions. Not long ago made novel molecules named proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. Just one ligand binds into https://www.directivepublications.org/journal-of-clinical-breast-cancer/